Now available IBTROZI™

IBTROZI™ (taletrectinib) capsules, for oral use, is a kinase inhibitor indicated for the treatment of adult patients with locally advanced or metastatic ROS1-positive non-small cell lung cancer (NSCLC).

Please see full prescribing information here.